Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry

Pharmacogenetics

Volumn 11, Issue 2, 2001, Pages 135-141

  Dettling, M ^a   Schaub, R T ^a   Mueller Oerlinghausen, B ^a   Roots, I ^a   Cascorbi, I ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adverse drug reaction; Agranulocytosis; Clozapine; HLA system

Indexed keywords

CLOZAPINE; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGE; AGED; AGRANULOCYTOSIS; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; ETHNOLOGY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC LINKAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CLOZAPINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 0035100014     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200103000-00004     Document Type: Article

References (37)

1. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States
2. An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201
3. Methods correcting for multiple testing: Operating characteristics
4. Drug-induced agranulocytosis: Review of possible mechanisms, and prospects for clozapine studies
5. No direct clinical relevance of the human leukocyte antigen (HLA-) system in clozapine-induced agranulocytosis
6. Adult linear IgA disease and chronic bullous disease of childhood: The association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression
7. The major histocompatibility complex region marked by HSP 70-1 und HSP 70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups
8. Genetic determinants of clozapine-induced agranulocytosis-recent results of HLA-subtyping in a non-Jewish Caucasian sample
9. Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: No associations with myeloperoxidase and cytochrome P4502D6
10. HLA-C revisited: Ten years of change
11. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors
12. N-desmethylclozapine: A clozapine metabolite that suppresses haematopoiesis
13. Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis
14. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients
15. The histocompatibility complex: Genetic polymorphism and disease susceptibility
16. HLA-B 38, DR 4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia
17. Allele typing of human TNFA 5′-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): Linkage disequilibrium with HLA class I and class II genes in Japanese
18. Complete sequence and gene map of a human major histocompatibility complex
19. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis
20. Allorecognition by NK cells: Non-self or no self?
21. What's wrong with Bonferroni adjustments
22. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis
23. Ethnicity and clozapine-induced agranulocytosis
24. Monte Carlo tests for associations between disease alleles at highly polymorphic loci
25. HLA and disease associations: Detecting the strongest association
26. Human leukocyte antigen system in clozapine-induced agranulocytosis
27. Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups
28. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions
29. Structural features associated with reactive metabolite formation in cloza-analogues
30. Genetic factors and risk of agranulocytosis from metamizol
31. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine
32. Mechanisms of disease: The pathophysiology of aquired aplastic anemia
33. HLA-associations in clozapine-induced agranulocytosis